Polymorphisms in the promoter region of the basic fibroblast growth factor gene are not associated with myocardial infarction in a slovene population with type 2 diabetes

Journal of International Medical Research

Volumn 37, Issue 5, 2009, Pages 1596-1603

  Kariz S ^a   Grabar, D ^b   Krkovic M ^c   Osredkar, J ^d   Petrovič, Daniel ^b,c  

^a Izola General Hospital   (Slovenia)

^b General Hospital Rakican   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Basic fibroblast growth factor gene; Myocardial infarction; Polymorphisms; Promoter region; Type 2 diabetes mellitus

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ADULT; ALLELE; ANAMNESIS; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PROMOTER REGION; PROTEIN BLOOD LEVEL; RISK FACTOR; SLOVENIA; WILD TYPE;

EID: 70449674884     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700538     Document Type: Article

References (27)

1. Moreno PR, Fuster V: New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 2004; 44: 2293-2300. (Pubitemid 39647601)
2. Flugelman MY, Virmani R, Correa R, et al: Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation 1993; 88: 2493-2500. (Pubitemid 23360172)
3. Brogi E,Winkles JA, Underwood R, et al: Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. J Clin Invest 1993; 92: 2408-2418. (Pubitemid 23333549)
4. Kumar S, West D, Shahabuddin S, et al: Angiogenesis factor from human myocardial infarcts. Lancet 1983; 322: 364-368.
5. Casscells W, Speir E, Sasse J, et al: Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest 1990; 85: 433-441. (Pubitemid 20070049)
6. Hughes SE, Crossman D, Hall PA: Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res 1993; 27: 1214-1219. (Pubitemid 23250899)
7. Hughes SE: Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries. Cardiovasc Res 1996; 32: 557-569.
8. Teshima-Kondo S, Kondo K, Prado-Lourenco L, et al: Hyperglycemia upregulates translation of the fibroblast growth factor 2 mRNA in mouse aorta via internal ribosome entry site. FASEB J 2004; 18: 1583-1585. (Pubitemid 39561640)
9. Karpen CW, Spanheimer RG, Randolph AL, et al: Tissue-specific regulation of basic fibroblast growth factor mRNA levels by diabetes. Diabetes 1992; 41: 222-226.
10. Panutsopulos D, Zafiropoulos A, Krambovitis E, et al: Peripheral monocytes from diabetic patients with coronary artery disease display increased bFGF and VEGF mRNA expression. J Transl Med 2003; 1: 6. (Pubitemid 39130341)
11. Lafage-Pochitaloff M, Galland F, Simonetti J, et al: The human basic fibroblast growth factor gene is located on the long arm of chromosome 4 at bands q26-q27. Oncogene Res 1990; 5: 241-244. (Pubitemid 20088247)
12. Beranek M, Tschoplova S, Kankova K, et al: Genetic variation in the promoter region of the basic fibroblast growth factor gene. Hum Immunol 2003; 64: 374-377. (Pubitemid 36255278)
13. Alpert JS, Thygesen K, Antman E, et al: Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969. (Pubitemid 30681627)
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26(suppl 1): S5-S20.
15. Araki S, Shimada Y, Kaji K, et al: Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 1990; 168: 1194-1200. (Pubitemid 20176006)
16. Terranova VP, DiFlorio R, Lyall RM, et al: Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol 1985; 101: 2330-2334. (Pubitemid 16169965)
17. Klein S, Roghani M, Rifkin DB: Fibroblast growth factors as angiogenesis factors: new insights into their mechanism of action. EXS 1997; 79: 159-192.
18. Lappalainen H, Laine P, Pentikainen MO, et al: Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler Thromb Vasc Biol 2004; 24: 1880-1885. (Pubitemid 39350307)
19. Zimering MB, Eng J: Increased basic fibroblast growth factor-like substance in plasma from a subset of middle-aged or elderly male diabetic patients with microalbuminuria or proteinuria. J Clin Endocrinol Metab 1996; 81: 4446-4452.
20. McClain DA, Paterson AJ, Roos MD, et al: Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 1992; 89: 8150-8154.
21. Schulz S, Kohler K, Schagdarsurengin U, et al: The human FGF2 level is influenced by genetic predisposition. Int J Cardiol 2005; 101: 265-271. (Pubitemid 40637623)
22. Beranek M, Kolar P, Tschoplova S, et al: Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy. Diabetes Res Clin Pract 2008; 79: 362-367.
23. Petrovic MG, Krkovic M, Osredkar J, et al: Polymorphisms in the promoter region of the basic fibroblast growth factor gene and proliferative diabetic retinopathy in Caucasians with type 2 diabetes. Clin Experiment Ophthalmol 2008; 36: 168-172.
24. Targher G, Bertolini L, Zenari L, et al: Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabet Med 2008; 25: 45-50.
25. Juutilainen A, Lehto S, Rönnemaa T, et al: Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 2007; 30: 292-299. (Pubitemid 46198333)
26. Haffner SM: Coronary heart disease in patients with diabetes. N Engl J Med 2000; 342: 1040-1042. (Pubitemid 30180652)
27. Bacci S, Villella M, Villella A, et al: Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol 2002; 147: 649-654. (Pubitemid 35414563)